Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)

China flag China · Delayed Price · Currency is CNY
18.29
-0.50 (-2.66%)
Apr 29, 2026, 3:12 PM CST
26.57%
Market Cap 4.82B
Revenue (ttm) 373.31M
Net Income (ttm) 89.14M
Shares Out 263.50M
EPS (ttm) 0.34
PE Ratio 53.62
Forward PE n/a
Dividend 0.15 (0.80%)
Ex-Dividend Date Jul 16, 2025
Volume 20,911,768
Average Volume 26,543,594
Open 23.64
Previous Close 18.79
Day's Range 18.03 - 23.64
52-Week Range 13.56 - 27.08
Beta 0.47
RSI 43.32
Earnings Date Apr 22, 2026

About Beijing Scitop Bio-tech

Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women’s health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy relief, blood pressure regulation, and mother-infant transmission, as well as exercise, bone, heart, and skin health applications. The company also off... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 295
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300858
Full Company Profile

Financial Performance

In 2025, Beijing Scitop Bio-tech's revenue was 365.92 million, an increase of 20.85% compared to the previous year's 302.79 million. Earnings were 94.52 million, an increase of 0.17%.

Financial Statements

News

There is no news available yet.